Increasing uptake of long‐acting reversible contraception with structured contraceptive counselling: cluster randomised controlled trial (the LOWE trial) K Emtell Iwarsson, N Envall, I Bizjak, J Bring, H Kopp Kallner, ... BJOG: An International Journal of Obstetrics & Gynaecology 128 (9), 1546-1554, 2021 | 30 | 2021 |
Use of effective contraception 6 months after emergency contraception with a copper intrauterine device or ulipristal acetate–a prospective observational cohort study N Envall, N Groes Kofoed, H Kopp‐Kallner Acta Obstetricia et Gynecologica Scandinavica 95 (8), 887-893, 2016 | 18 | 2016 |
Use of contraception and attitudes towards contraceptive use in Swedish women: an internet-based nationwide survey N Envall, T Wallström, K Gemzell Danielsson, H Kopp Kallner The European Journal of Contraception & Reproductive Health Care 27 (5), 409-417, 2022 | 14 | 2022 |
Long-acting reversible contraception and satisfaction with structured contraceptive counselling among non-migrant, foreign-born migrant and second-generation migrant women … KE Iwarsson, EC Larsson, I Bizjak, N Envall, HK Kallner, ... BMJ sexual & reproductive health 48 (2), 128-136, 2022 | 13 | 2022 |
Evaluation of satisfaction with a model of structured contraceptive counseling: results from the LOWE trial N Envall, K Emtell Iwarsson, I Bizjak, K Gemzell Danielsson, ... Acta Obstetricia et Gynecologica Scandinavica 100 (11), 2044-2052, 2021 | 12 | 2021 |
The 13.5-mg, 19.5-mg, and 52-mg levonorgestrel-releasing intrauterine systems and risk of ectopic pregnancy K Elgemark, S Graner, J McTaggart, JR Löfström, D Sörensen, N Envall, ... Obstetrics & Gynecology 140 (2), 227-233, 2022 | 7 | 2022 |
Intrauterine mepivacaine instillation for pain relief during intrauterine device insertion in nulliparous women: a double-blind, randomized, controlled trial N Envall, HG Lagercrantz, J Sunesson, HK Kallner Contraception 99 (6), 335-339, 2019 | 7 | 2019 |
Placement of an intrauterine device within 48 hours after early medical abortion—a randomized controlled trial S Hogmark, KL Liljeblad, N Envall, K Gemzell-Danielsson, HK Kallner American Journal of Obstetrics and Gynecology 228 (1), 53. e1-53. e9, 2023 | 4 | 2023 |
One‐year follow up of contraceptive use and pregnancy rates after early medical abortion: Secondary outcomes from a randomized controlled trial of immediate post‐abortion … S Hogmark, N Envall, K Gemzell‐Danielsson, H Kopp Kallner Acta Obstetricia et Gynecologica Scandinavica 102 (12), 1694-1702, 2023 | 1 | 2023 |
Provision of long‐acting reversible contraception at surgical abortion—A cross‐sectional nationwide register study S Hogmark, N Envall, A Wikman, C Skoglund, H Kopp Kallner, ... Acta obstetricia et gynecologica Scandinavica 101 (1), 77-83, 2022 | 1 | 2022 |
Contraceptive uptake and compliance after structured contraceptive counseling‐secondary outcomes of the LOWE trial I Bizjak, N Envall, K Emtell Iwarsson, H Kopp Kallner, ... Acta Obstetricia et Gynecologica Scandinavica, 2024 | | 2024 |
The use and access to contraception in Sweden during the COVID-19 pandemic period N Envall, K Gemzell Danielsson, H Kopp Kallner The European Journal of Contraception & Reproductive Health Care 28 (5), 275-281, 2023 | | 2023 |
Mental Health Conditions in the Postpartum Period: A Scoping Study O Ojomo, O Alesinloye-King, K Erlandsson, K Ängeby, N Envall | | 2023 |
Mental Health Conditions in the Postpartum Period: A Scoping Study (preprint) O Ojomo, O Alesinloye-King, K Erlandsson, K Ängeby, N Envall | | 2023 |
an international reproductive health journal K Gemzell-Danielsson, R Sitruk-Ware, MD Creinin, M Thomas, ... | | 2019 |
Increasing Uptake of Long-Acting Reversible Contraception—LARC N Envall PQDT-Global, 2019 | | 2019 |
Placement of an Intrauterine Device within 48 Hours Versus at Two to Four Weeks after Second Trimester Medical Abortion (Intram): A Randomised, Open-Label, Phase 3, Superiority … S Hogmark, J Rydelius, N Envall, P Teleman, K Gemzell-Danielsson, ... Open-Label, Phase 3, 0 | | |